loader
Please Wait
Applying Filters...

Euroapi Company Header Euroapi Company Header

X

List of CEND-1 NDC API suppliers/manufacturers & exporters

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 DARMERICA, LLC (27)

02 Qingdao Biopeptek Co., Ltd. (3)

filter

01 ACTH 1-24 (Tetracosactide Acetate) (1)

02 ARA290 Acetate (1)

03 Bremelanotide Acetate (1)

04 Buserelin Acetate (1)

05 Elamipretide (SS-31) Acetate (1)

06 FGL Acetate (1)

07 FOX04-DRI (1)

08 FOXO4-DRI Acetate (1)

09 Gonadorelin Acetate (1)

10 Hexarelin Acetate (1)

11 Humanin Acetate (1)

12 KCF-18 Acetate (1)

13 KPV (1)

14 KPV Acetate (1)

15 Kisspeptin-10 Acetate (1)

16 Larazotide Acetate (1)

17 Long R3 IGF-1 (1)

18 MOTs-C Acetate (1)

19 Melanotan I Acetate (1)

20 Melanotan II Acetate (1)

21 Met-Enkephalin Acetate (1)

22 P21 Peptide Acetate (1)

23 PE 22-28 Acetate (1)

24 PTD-DBM (1)

25 PTD-DBM Acetate (1)

26 Pinealon Acetate (1)

27 Selank Acetate (1)

28 Setmelanotide (RM-493) Acetate (1)

29 Vasoactive Intestinal Peptide (VIP) Acetate (1)

30 iRGD Acetate (1)

filter

01 U.S.A (30)

URL Supplier Web Content
Bremelanotide Acetate
POWDER (1g/g)
BULK INGREDIENT
71052-359
2019-11-08
2025-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Buserelin Acetate
POWDER (1g/g)
BULK INGREDIENT
71052-358
2019-12-20
2025-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
PTD-DBM Acetate
POWDER (1g/g)
BULK INGREDIENT
71052-546
2019-09-20
2025-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
ACTH 1-24 (Tetracosactide Acetate)
POWDER (1g/g)
BULK INGREDIENT
71052-180
2020-03-17
2025-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Vasoactive Intestinal Peptide (VIP) Acetate
POWDER (0.5g/.5g)
BULK INGREDIENT FOR ...
71052-093
2019-11-08
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
MOTs-C Acetate
POWDER (1g/g)
BULK INGREDIENT
71052-523
2019-11-20
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Selank Acetate
POWDER (1g/g)
BULK INGREDIENT
71052-517
2019-12-20
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
iRGD Acetate
POWDER (1g/g)
BULK INGREDIENT
71052-073
2019-08-21
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Long R3 IGF-1
POWDER (10mg/10mg)
BULK INGREDIENT
71052-364
2019-11-15
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
KCF-18 Acetate
POWDER (1g/g)
BULK INGREDIENT
71052-013
2023-12-27
2025-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 1392278-76-0 / CEND-1 API manufacturers, exporters & distributors?

CEND-1 manufacturers, exporters & distributors 1

17

PharmaCompass offers a list of CEND-1 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right CEND-1 manufacturer or CEND-1 supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred CEND-1 manufacturer or CEND-1 supplier.

PharmaCompass also assists you with knowing the CEND-1 API Price utilized in the formulation of products. CEND-1 API Price is not always fixed or binding as the CEND-1 Price is obtained through a variety of data sources. The CEND-1 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

CEND-1

Synonyms

1392278-76-0, Unii-z8mxu5gh4q, Irgd peptide, Irgd, Irgd-peptide, Z8mxu5gh4q

Cas Number

1392278-76-0

About CEND-1

Internalized-arginylglycylaspartic Acid Cyclic Peptide is a 9 amino acid-based cyclic, tumor specific homing, arginine-glycine-aspartic acid (RGD)-based peptide (CRGDKRGPDC), with tumor penetrating activity. The iRGD contains the RGD motif as well as the C-terminal end binding (CendR) motif that increases internalization. Upon administration, the RGD motif of the iRGD peptide is able to specifically target tumors by binding to alphavbeta3/alphavbeta5 integrins on tumor endothelium. In turn, iRGD is cleaved by specific tumor proteases, which exposes the positively charged CendR motif. This motif binds to neuropilin-1 (NRP-1), a receptor overexpressed on certain tumor cells. This increases vascular permeability of tumor blood vessels and promotes tumor penetration. Compared to other RGD peptides, this agent is able to both improve delivery and increase the accumulation of co-administered or conjugated chemotherapeutic agents in the tumor.

CEND-1 Manufacturers

A CEND-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CEND-1, including repackagers and relabelers. The FDA regulates CEND-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CEND-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

CEND-1 Suppliers

A CEND-1 supplier is an individual or a company that provides CEND-1 active pharmaceutical ingredient (API) or CEND-1 finished formulations upon request. The CEND-1 suppliers may include CEND-1 API manufacturers, exporters, distributors and traders.

CEND-1 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CEND-1 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for CEND-1 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture CEND-1 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain CEND-1 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CEND-1 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of CEND-1 suppliers with NDC on PharmaCompass.

CEND-1 Manufacturers | Traders | Suppliers

CEND-1 Manufacturers, Traders, Suppliers 1
89

We have 2 companies offering CEND-1

Get in contact with the supplier of your choice:

  1. Biopeptek Pharmaceuticals
  2. Darmerica
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY